108 related articles for article (PubMed ID: 11469335)
1. Synthesis of a non-natural T-antigen containing glycosphingolipid.
Cipolla L; Meldal M
Carbohydr Lett; 2000; 4(1):29-34. PubMed ID: 11469335
[TBL] [Abstract][Full Text] [Related]
2. Total synthesis of the potential anticancer vaccine KH-1 adenocarcinoma antigen.
Deshpande PP; Danishefsky SJ
Nature; 1997 May; 387(6629):164-6. PubMed ID: 9144285
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activities of glycosphingolipid analogues from marine sponge Aplysinella rhax.
Hada N; Nakashima T; Shrestha SP; Masui R; Narukawa Y; Tani K; Takeda T
Bioorg Med Chem Lett; 2007 Nov; 17(21):5912-5. PubMed ID: 17827010
[TBL] [Abstract][Full Text] [Related]
4. Synthetic studies on glycosphingolipids from protostomia phyla: synthesis of a glycosphingolipid analogue from the parasite Spirometra erinacei.
Hada N; Kuroda M; Takeda T
Chem Pharm Bull (Tokyo); 2000 Aug; 48(8):1160-5. PubMed ID: 10959580
[TBL] [Abstract][Full Text] [Related]
5. Calix[4]arene decorated with four Tn antigen glycomimetic units and P3CS immunoadjuvant: synthesis, characterization, and anticancer immunological evaluation.
Geraci C; Consoli GM; Galante E; Bousquet E; Pappalardo M; Spadaro A
Bioconjug Chem; 2008 Mar; 19(3):751-8. PubMed ID: 18293897
[TBL] [Abstract][Full Text] [Related]
6. CTL-based cancer preventive/therapeutic vaccines for carcinomas: role of tumour-associated carbohydrate antigens.
Franco A
Scand J Immunol; 2005 May; 61(5):391-7. PubMed ID: 15882430
[TBL] [Abstract][Full Text] [Related]
7. Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen.
Buskas T; Ingale S; Boons GJ
Angew Chem Int Ed Engl; 2005 Sep; 44(37):5985-8. PubMed ID: 16108081
[No Abstract] [Full Text] [Related]
8. Synthesis of cancer-associated glycoantigens: stage-specific embryonic antigen 3 (SSEA-3).
Pornsuriyasak P; Demchenko AV
Carbohydr Res; 2006 Jul; 341(10):1458-66. PubMed ID: 16643871
[TBL] [Abstract][Full Text] [Related]
9. Glycosphingolipid structural analysis and glycosphingolipidomics.
Levery SB
Methods Enzymol; 2005; 405():300-69. PubMed ID: 16413319
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of tumor-associated glycopeptide antigens for the development of tumor-selective vaccines.
Dziadek S; Kunz H
Chem Rec; 2004; 3(6):308-21. PubMed ID: 14991920
[TBL] [Abstract][Full Text] [Related]
11. Convenient structural analysis of glycosphingolipids using MALDI-QIT-TOF mass spectrometry with increased laser power and cooling gas flow.
Suzuki Y; Suzuki M; Ito E; Goto-Inoue N; Miseki K; Iida J; Yamazaki Y; Yamada M; Suzuki A
J Biochem; 2006 Apr; 139(4):771-7. PubMed ID: 16672278
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of the glycosphingolipid beta-galactosyl ceramide and analogues via olefin cross metathesis.
Rai AN; Basu A
J Org Chem; 2005 Sep; 70(20):8228-30. PubMed ID: 16277356
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen.
Vichier-Guerre S; Lo-Man R; Huteau V; Dériaud E; Leclerc C; Bay S
Bioorg Med Chem Lett; 2004 Jul; 14(13):3567-70. PubMed ID: 15177475
[TBL] [Abstract][Full Text] [Related]
14. Fluorinated glycosyl amino acids for mucin-like glycopeptide antigen analogues.
Wagner S; Mersch C; Hoffmann-Röder A
Chemistry; 2010 Jun; 16(24):7319-30. PubMed ID: 20461825
[TBL] [Abstract][Full Text] [Related]
15. Glycosylinositolphosphoceramides in Aspergillus fumigatus.
Simenel C; Coddeville B; Delepierre M; Latgé JP; Fontaine T
Glycobiology; 2008 Jan; 18(1):84-96. PubMed ID: 17971386
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of selected LeY and KH-1 analogues: a medicinal chemistry approach to vaccine optimization.
Spassova MK; Bornmann WG; Ragupathi G; Sukenick G; Livingston PO; Danishefsky SJ
J Org Chem; 2005 Apr; 70(9):3383-95. PubMed ID: 15844973
[TBL] [Abstract][Full Text] [Related]
17. Structural elucidation of zwitterionic carbohydrates derived from glycosphingolipids of the porcine parasitic nematode Ascaris suum.
Friedl CH; Lochnit G; Zähringer U; Bahr U; Geyer R
Biochem J; 2003 Jan; 369(Pt 1):89-102. PubMed ID: 12234251
[TBL] [Abstract][Full Text] [Related]
18. Integrated mass spectrometric strategy for characterizing the glycans from glycosphingolipids and glycoproteins: direct identification of sialyl Le(x) in mice.
Parry S; Ledger V; Tissot B; Haslam SM; Scott J; Morris HR; Dell A
Glycobiology; 2007 Jun; 17(6):646-54. PubMed ID: 17341505
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic synthesis of the tumor-associated (2,3)-sialyl-T antigen and its incorporation into glycopeptide antigens from the mucins MUC1 and MUC4.
Dziadek S; Brocke C; Kunz H
Chemistry; 2004 Sep; 10(17):4150-62. PubMed ID: 15352098
[TBL] [Abstract][Full Text] [Related]
20. Structural characterization of glycosylinositolphospholipids with a blood group type B sugar unit from the edible mushroom, Hypsizygus marmoreus.
Itonori S; Yamawaki S; Aoki K; Yamamoto K; Hada N; Takeda T; Dulaney JT; Sugita M
Glycobiology; 2008 Jul; 18(7):540-8. PubMed ID: 18450973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
